CROTALIDAE IMMUNE F(AB)2(EQUINE)

CROTALIDAE IMMUNE F(AB)2(EQUINE) was reported 187 times

These side effects are most commonly reported by patients taking CROTALIDAE IMMUNE F(AB)2(EQUINE):

# Side effect Count
0 URTICARIA 64
1 PRURITUS 54
2 RASH 32
3 ANAPHYLACTIC REACTION 24
4 DYSPNOEA 18
5 ERYTHEMA 17
6 OFF LABEL USE 14
7 HYPERSENSITIVITY 13
8 NAUSEA 11
9 UNDERDOSE 11
10 HYPOTENSION 10
11 SWELLING 10
12 THERAPY CHANGE 10
13 PLATELET COUNT DECREASED 9
14 PROTHROMBIN TIME PROLONGED 9
15 SWELLING FACE 9
16 COAGULOPATHY 8
17 FLUSHING 8
18 INFUSION RELATED REACTION 8
19 TACHYCARDIA 8
20 WHEEZING 8
21 BLOOD FIBRINOGEN DECREASED 7
22 CHEST DISCOMFORT 7
23 SERUM SICKNESS 7
24 VOMITING 7
25 ANGIOEDEMA 6
26 MOBILITY DECREASED 6
27 PHARYNGEAL SWELLING 6
28 THROMBOCYTOPENIA 6
29 CHEST PAIN 5
30 DEATH 5
31 BLOOD CREATINE PHOSPHOKINASE INCREASED 4
32 PAIN 4
33 PARAESTHESIA ORAL 4
34 SWOLLEN TONGUE 4
35 ANAPHYLACTOID REACTION 3
36 ANXIETY 3
37 BLOOD PRESSURE DECREASED 3
38 CONDITION AGGRAVATED 3
39 COUGH 3
40 DIZZINESS 3
41 DRUG INEFFECTIVE 3
42 HAEMOGLOBIN DECREASED 3
43 HYPERHIDROSIS 3
44 LIP SWELLING 3
45 NECROSIS 3
46 PERIPHERAL SWELLING 3
47 RASH ERYTHEMATOUS 3
48 RESPIRATORY DISTRESS 3
49 SHOCK 3
50 SKIN GRAFT 3
51 SWELLING OF EYELID 3
52 TISSUE INJURY 3
53 ABDOMINAL PAIN 2
54 ACUTE KIDNEY INJURY 2
55 ACUTE RESPIRATORY FAILURE 2
56 ADVERSE DRUG REACTION 2
57 ARTHRALGIA 2
58 CELLULITIS 2
59 CHOLECYSTITIS 2
60 CHOLELITHIASIS 2
61 DISCOMFORT 2
62 FASCIOTOMY 2
63 HAEMATOCRIT DECREASED 2
64 KOUNIS SYNDROME 2
65 MALAISE 2
66 MUSCULOSKELETAL STIFFNESS 2
67 MYALGIA 2
68 NASAL CONGESTION 2
69 OEDEMA 2
70 OROPHARYNGEAL OEDEMA 2
71 PYREXIA 2
72 RASH MACULO-PAPULAR 2
73 RASH PRURITIC 2
74 SUPRAVENTRICULAR TACHYCARDIA 2
75 ABDOMINAL PAIN UPPER 1
76 ACCIDENTAL UNDERDOSE 1
77 AGONAL RESPIRATION 1
78 ARTERIOSPASM CORONARY 1
79 ASTHENIA 1
80 BLISTER 1
81 BLOOD CREATINE INCREASED 1
82 BRADYCARDIA 1
83 BRAIN OEDEMA 1
84 BULLOUS HAEMORRHAGIC DERMATOSIS 1
85 CARDIAC FAILURE 1
86 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1
87 COMPARTMENT SYNDROME 1
88 DEEP VEIN THROMBOSIS 1
89 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 1
90 DRUG HYPERSENSITIVITY 1
91 DYSPHAGIA 1
92 EAR SWELLING 1
93 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1
94 FACE OEDEMA 1
95 FATIGUE 1
96 FEELING COLD 1
97 FEELING HOT 1
98 FIBRIN D DIMER INCREASED 1
99 GAIT DISTURBANCE 1
100 HAEMATOCHEZIA 1
101 HAEMATURIA 1
102 HAEMOPTYSIS 1
103 HEADACHE 1
104 HEART RATE INCREASED 1
105 HYPERTENSION 1
106 HYPERTHERMIA 1
107 HYPOXIA 1
108 INCORRECT DOSE ADMINISTERED 1
109 INFUSION SITE COLDNESS 1
110 INFUSION SITE PAIN 1
111 INJECTION SITE ERYTHEMA 1
112 INSOMNIA 1
113 INTENTIONAL PRODUCT MISUSE 1
114 IRRITABILITY 1
115 LIVER INJURY 1
116 LOSS OF CONSCIOUSNESS 1
117 MENTAL STATUS CHANGES 1
118 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 1
119 MIGRAINE 1
120 NEUROTOXICITY 1
121 NONSPECIFIC REACTION 1
122 OBSTRUCTIVE AIRWAYS DISORDER 1
123 ODYNOPHAGIA 1
124 OEDEMA PERIPHERAL 1
125 OROPHARYNGEAL PAIN 1
126 OROPHARYNGEAL SWELLING 1
127 OXYGEN SATURATION DECREASED 1
128 PAIN IN EXTREMITY 1
129 PARAESTHESIA 1
130 PATIENT UNCOOPERATIVE 1
131 PERIORBITAL OEDEMA 1
132 PRODUCT ADMINISTRATION ERROR 1
133 PRODUCT NAME CONFUSION 1
134 PRODUCT PREPARATION ERROR 1
135 PRODUCT WITH QUALITY ISSUE ADMINISTERED 1
136 PULMONARY EMBOLISM 1
137 RENAL PAIN 1
138 RESPIRATION ABNORMAL 1
139 RESPIRATORY FAILURE 1
140 RHINORRHOEA 1
141 SCRATCH 1
142 SKIN BURNING SENSATION 1
143 SKIN NECROSIS 1
144 SNEEZING 1
145 STRIDOR 1
146 SUBDURAL HAEMORRHAGE 1
147 SYNCOPE 1
148 TACHYPNOEA 1
149 TENDERNESS 1
150 THERAPEUTIC PRODUCT EFFECT DECREASED 1
151 THERAPY CESSATION 1
152 TONGUE PRURITUS 1
153 TYPE I HYPERSENSITIVITY 1
154 UNRESPONSIVE TO STIMULI 1
155 VISION BLURRED 1
156 VOMITING PROJECTILE 1
157 WOUND 1
158 WOUND NECROSIS 1